Development of ISB 1442, a CD38 and CD47 bispecific biparatopic antibody innate cell modulator for the treatment of multiple myeloma
开发 ISB 1442,一种用于治疗多发性骨髓瘤的 CD38 和 CD47 双特异性双互补抗体先天细胞调节剂
期刊:Nature Communications
影响因子:14.7
doi:10.1038/s41467-024-46310-y
C Grandclément #, C Estoppey #, E Dheilly #, M Panagopoulou, T Monney, C Dreyfus, J Loyau, V Labanca, A Drake, S De Angelis, A Rubod, J Frei, L N Caro, S Blein, E Martini, M Chimen, T Matthes, Z Kaya, C M Edwards, J R Edwards, E Menoret, C Kervoelen, C Pellat-Deceunynck, P Moreau, M L Mbow, A Srivas